Moreover, HLA-E-VL9 antibodies showed a trend to have shorter heavy-chain complementarity determining region 3 (CDR3) lengths than reference antibodies (Fig. 5h ), while no difference was observed for light-chain CDR3 (Fig. 5i ).
← all excerpts
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.
1
—
—